List of Oncology Medication For

Blood Disorders

Hematologic diseases are disorders which primarily affect the blood and blood-forming organs. Hematologic diseases include rare genetic disorders, anemia, HIV, sickle cell disease and complications from chemotherapy or transfusions.

If Blood Disorders Medicines are not yet approved or available in your area, you may give a request, to get access price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

Niktimvo (axatilimab-csfr) Injection

Blood Disorders, Bone marrow, Transplant

Brand Name: Niktimvo. Generic Name: (axatilimab-csfr). It is used to treat chronic graft-versus-host disease (cGVHD).

Niktimvo (axatilimab-csfr) is indicated for the treatment of chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg.

Brand Name:	Niktimvo
Generic Name:	axatilimab-csfr
Strength:	• Injection: 50 mg/mL solution in a single-dose vial.
Manufacturer:	Incyte
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Niktimvo (axatilimab-csfr) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Nilotinib Capsules

Leukemia

nilotinib Capsules
for oral use Initial U.S. Approval: 2007

Tasigna (nilotinib) is a prescription medicine used to treat chronic myelogenous leukaemia (CML) in patients who have the Philadelphia chromosome. It may be used in people who have been newly diagnosed or who cannot take other cancer medicines (including imatinib).

Facts about nilotinib Capsules

Disease Indications-Leukemia
Manufacturer-Novartis
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Nilotinib Capsules” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Obinutuzumab Injection

Leukemia

obinutuzumab injection
for intravenous use Initial U.S. Approval: 2013

Facts about obinutuzumab injection

Approval Date: 2013
Proprietary Name: On Request
Active Ingredient(s): obinutuzumab
Dosage Forms And Strengths: 1000 mg/40 mL (25 mg/mL) single-dose vial.
Company: Roche
Current indications: chronic lymphocytic leukemia; follicular lymphoma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “obinutuzumab injection” based on the information you provide.

OGSIVEO (nirogacestat) tablets

Blood Disorders

OGSIVEO (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023

Ogsiveo (nirogacestat) is an oral, selective, gamma-secretase inhibitor that may be used to treat adults with progressing desmoid tumors who require systemic treatment. Desmoid tumors are rare and aggressive tumors of the soft tissues.

Brand Name:	OGSIVEO
Generic Name:	nirogacestat
Strength:	• Tablets: 50 mg.
Manufacturer:	SpringWorks Therapeutics Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “OGSIVEO (nirogacestat) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for OGSIVEO (nirogacestat) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

OJJAARA (momelotinib) tablets

Blood Disorders, Anemia, Myeloid

OJJAARA (momelotinib) tablets, for oral use Initial U.S. Approval: 2023

OJJAARA is used to treat a certain type of cancer (myelofibrosis) in people with anemia (low red blood cell count). Momelotinib belongs to a class of drugs known as kinase inhibitors. It works by blocking your body from producing substances called growth factors.

Brand Name:	OJJAARA
Generic Name:	momelotinib
Strength:	• Tablets: 100 mg, 150 mg, 200 mg.
Manufacturer:	GlaxoSmithKline
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “OJJAARA (momelotinib) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for OJJAARA (momelotinib) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Pegaspargase injection

Leukemia

Pegaspargase injection, for intramuscular or intravenous use. Initial U.S. Approval: 1994

Generic Name – Pegaspargase injection
Medicine Type – Injection / Intrevenous
Manufacturer Name – Servier IP UK Ltd
Approval Year – 2006
Approved by – Food and Drug Administration (FDA)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import pegaspargase injection” based on the information you provide.

Pomalidomide capsules

Multiple Myeloma

pomalidomide capsules
for oral use Initial U.S. Approval: 2013

pomalidomide capsules is a thalidomide analogue indicated, in combination with dexamethasone, for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy

Facts about pomalidomide capsules

Approval Date: 2013
Proprietary Name: On Request
Active Ingredient(s): pomalidomide capsules
Dosage Forms And Strengths: Capsules: 1 mg, 2 mg, 3 mg, and 4 mg
Current indications: multiple myeloma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “pomalidomide capsules” based on the information you provide.

Ponatinib tablets

Leukemia

Ponatinib injection
for subcutaneous use Initial U.S. Approval: 2012

Ponatinib tablets is “used to treat patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Ph+ ALL for whom no other tyrosine kinase inhibitor (TKI)“. ICLUSIG Tablets is a “prescription medicine”. It is available in “form and strength” Tablets: 15 mg and 45 mg. ICLUSIG Tablets can be obtained in India upon request.
To inquire about the ICLUSIG (ponatinib) tablets“offer price in India”, “shipping process”, and the “estimated time of availability in India”, please get in touch at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.”

Facts about your medicine

Approval Date: 2012
Proprietary Name: On Request
Active Ingredient(s): Ponatinib tablets
Dosage Forms And Strengths:
Manufacturer:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Ponatinib tablets” based on the information you provide.

PRAXBIND (idarucizumab) Injection

Kidney, Blood Disorders

PRAXBIND (idarucizumab) injection, for intravenous use Initial U.S. Approval: 2015

Praxbind is a medicine used to neutralise the effects of dabigatran (the active substance of Pradaxa), a medicine that treats and prevents blood clots. Praxbind is used to rapidly stop the anticlotting effect of dabigatran, before emergency surgery or in case of life-threatening bleeding.

Brand Name:	PRAXBIND
Generic Name:	idarucizumab
Strength:	Injection: 2.5 g/50 mL solution in a single-use vial
Manufacturer:	Boehringer Ingelheim Pharmaceuticals, Inc
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “PRAXBIND (idarucizumab) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for PRAXBIND (idarucizumab) Injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Revuforj (revumenib) Tablets

Leukemia, Blood Disorders

Brand Name: Revuforj. Generic Name: (revumenib). It is used to treat relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation.

REVUFORJ is a menin inhibitor indicated for the treatment of relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation in adult and pediatric patients 1 year and older.

Brand Name:	Revuforj
Generic Name:	revumenib
Strength:	• Tablets: 25 mg, 110 mg, 160 mg
Manufacturer:	Syndax Pharmaceuticals, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Revuforj (revumenib) Tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Blood Disorders

Brand Name: Niktimvo. Generic Name: (axatilimab-csfr). It is used to treat chronic graft-versus-host disease (cGVHD).

nilotinib Capsules for oral use Initial U.S. Approval: 2007

Facts about nilotinib Capsules

Access the best support services globally

obinutuzumab injection for intravenous use Initial U.S. Approval: 2013

Facts about obinutuzumab injection

Access the best support services globally

OGSIVEO (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023

OJJAARA (momelotinib) tablets, for oral use Initial U.S. Approval: 2023

Pegaspargase injection, for intramuscular or intravenous use. Initial U.S. Approval: 1994

Access the best support services globally

pomalidomide capsules for oral use Initial U.S. Approval: 2013

Facts about pomalidomide capsules

Access the best support services globally

Ponatinib injection for subcutaneous use Initial U.S. Approval: 2012

Facts about your medicine

Access the best support services globally

PRAXBIND (idarucizumab) injection, for intravenous use Initial U.S. Approval: 2015

Brand Name: Revuforj. Generic Name: (revumenib). It is used to treat relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation.

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

nilotinib Capsules
for oral use Initial U.S. Approval: 2007

obinutuzumab injection
for intravenous use Initial U.S. Approval: 2013

pomalidomide capsules
for oral use Initial U.S. Approval: 2013

Ponatinib injection
for subcutaneous use Initial U.S. Approval: 2012